×
About 2,748 results

ALLMedicine™ Pancreas Transplantation Center

Research & Reviews  1,331 results

Pancreas transplantation would be easy if the recipients were not diabetic: A practical...
https://doi.org/10.1111/ctr.14270
Clinical Transplantation; Cerise A, Chen JM et. al.

Mar 1st, 2021 - Diabetes mellitus remains a major public health problem throughout the United States with over $300 billion spent in total cost of care annually. In addition to being a leading cost of kidney failure, diabetes causes a host of secondary hyperglyce...

Pancreas preservation time as a predictor of prolonged hospital stay after pancreas tra...
https://doi.org/10.1177/0300060520987059
The Journal of International Medical Research; Mei S, Huang Z et. al.

Feb 25th, 2021 - Length of hospital stay is a sensitive indicator of short-term prognosis. In this retrospective study, we investigated how pancreas preservation time affects length of hospital stay after pancreas transplantation. Patients receiving pancreas trans...

Risk indices predicting graft use, graft and patient survival in solid pancreas transpl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901078
BMC Gastroenterology; Ling JEH, Coughlan T et. al.

Feb 24th, 2021 - Risk indices such as the pancreas donor risk index (PDRI) and pre-procurement pancreas allocation suitability score (P-PASS) are utilised in solid pancreas transplantation however no review has compared all derived and validated indices in this fi...

Frailty in Pancreas Transplantation.
https://doi.org/10.1097/TP.0000000000003586
Transplantation Parajuli S, Aziz F et. al.

Feb 19th, 2021 - There are a variety of definitions and criteria used in clinical practice to define frailty. In the absence of a gold standard definition, frailty has been operationally defined as meeting three out of five phenotypic criteria indicating compromis...

see more →

Clinicaltrials.gov  1,373 results

Pancreas transplantation would be easy if the recipients were not diabetic: A practical...
https://doi.org/10.1111/ctr.14270
Clinical Transplantation; Cerise A, Chen JM et. al.

Mar 1st, 2021 - Diabetes mellitus remains a major public health problem throughout the United States with over $300 billion spent in total cost of care annually. In addition to being a leading cost of kidney failure, diabetes causes a host of secondary hyperglyce...

Pancreas preservation time as a predictor of prolonged hospital stay after pancreas tra...
https://doi.org/10.1177/0300060520987059
The Journal of International Medical Research; Mei S, Huang Z et. al.

Feb 25th, 2021 - Length of hospital stay is a sensitive indicator of short-term prognosis. In this retrospective study, we investigated how pancreas preservation time affects length of hospital stay after pancreas transplantation. Patients receiving pancreas trans...

Risk indices predicting graft use, graft and patient survival in solid pancreas transpl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901078
BMC Gastroenterology; Ling JEH, Coughlan T et. al.

Feb 24th, 2021 - Risk indices such as the pancreas donor risk index (PDRI) and pre-procurement pancreas allocation suitability score (P-PASS) are utilised in solid pancreas transplantation however no review has compared all derived and validated indices in this fi...

Frailty in Pancreas Transplantation.
https://doi.org/10.1097/TP.0000000000003586
Transplantation Parajuli S, Aziz F et. al.

Feb 19th, 2021 - There are a variety of definitions and criteria used in clinical practice to define frailty. In the absence of a gold standard definition, frailty has been operationally defined as meeting three out of five phenotypic criteria indicating compromis...

see more →

News  43 results

Belatacept -- A Welcome New Transplantation Drug
https://www.medscape.com/viewarticle/744832

Jun 19th, 2011 - Jeffrey S. Berns, MD: Hello. This is Jeffrey Berns from the University of Pennsylvania School of Medicine in Philadelphia. I'm Editor-in-Chief of Medscape Nephrology. I am here with Dr. Roy Bloom, who is our Medical Director for Kidney and Pancrea...

Extended CMV Prophylaxis After Kidney, Pancreas Transplants Lowers Risk, Costs
https://www.medscape.com/viewarticle/709172

Sep 16th, 2009 - September 17, 2009 — Increasing the period of preventive treatment with valganciclovir from 3 to 6 months after kidney and/or pancreas transplantation can reduce the risk for cytomegalovirus (CMV) disease, leading to significant overall cost savin...

Antimicrobial Prophylaxis for Pancreas Transplantation
https://www.medscape.com/viewarticle/516821

Nov 28th, 2005 - Question What is current recommended practice for prophylactic antibacterial and antifungal prophylaxis in kidney-pancreas and pancreas alone transplantation? John Radomski, MD Response from Robert J. Stratta, MD Pancreas and kidney-pancreas trans...

Prevention of Thrombosis After Pancreas Transplantation
https://www.medscape.com/viewarticle/503838

Apr 28th, 2005 - Question Because of the high risk of posttransplant pancreatic allograft thrombosis, are there guidelines for anticoagulation in pancreas transplant recipients? Junaid Ahmed, MD Response from Robert J. Stratta, MD Unlike other solid organ transpla...

Criteria for Cadaveric Pancreas Donation
https://www.medscape.com/viewarticle/488256

Sep 8th, 2004 - Question What are the acceptable donor criteria for cadaveric pancreas donation? F.R. Calder, Mb ChB Response from Robert J. Stratta, MD Donor selection and organ procurement are paramount to the success of pancreas transplantation. Most heart-bea...

see more →

Patient Education  1 results see all →